✦ LIBER ✦

Dasatinib combined with docetaxel for castration-resistant prostate cancer : Results from a phase 1-2 study

✍ Scribed by John C. Araujo; Paul Mathew; Andrew J. Armstrong; Edward L. Braud; Edwin Posadas; Mathew Lonberg; Gary E. Gallick; Géralyn C. Trudel; Prashni Paliwal; Shruti Agrawal; Christopher J. Logothetis

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 182 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and docetaxel in metastatic,

Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer : Results from a phase 2 trial

✍ Jorge A. Garcia; Thomas E. Hutson; Dale Shepard; Paul Elson; Robert Dreicer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

A phase 2 study of estramustine, docetax

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer : Results from Cancer and Leukemia Group B Study 90006

✍ Joel Picus; Susan Halabi; W. Kevin Kelly; Nicholas J. Vogelzang; Young E. Whang; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Phase 2 trial of weekly intravenous 1,25

Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration-resistant prostate cancer

✍ Manpreet K. Chadha; Lili Tian; Terry Mashtare; Valencia Payne; Carrie Silliman; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Ixabepilone, mitoxantrone, and prednison

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

A phase 2 study of cetuximab in combinat

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

✍ Edward S. Kim; Ann M. Mauer; William N. William Jr; Hai T. Tran; Diane Liu; Jack 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views